Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proton Image-Guided Radiation Assignment for Therapeutic Escalation Via Selection of Locally Advanced Head and Neck Cancer Patients [PIRATES]

NCT04870840 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04870840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proton Image-Guided Radiation Assignment for Therapeutic Escalation Via Selection of Locally Advanced Head and Neck Cancer Patients [PIRATES]
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 1
Overall status
Completed
Start date
October 19, 2020
Completion date
July 11, 2023
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced head and neck squamous cell carcinoma, locally advanced hypopharyngeal squamous cell carcinoma, locally advanced laryngeal squamous cell carcinoma, locally advanced nasopharyngeal squamous cell carcinoma, locally advanced oral cavity squamous cell carcinoma, locally advanced oropharyngeal squamous cell carcinoma, malignant posterior tongue neoplasm, stage ii cutaneous squamous cell carcinoma of the head and neck ajcc v8, stage ii hypopharyngeal carcinoma ajcc v8, stage ii laryngeal cancer ajcc v8, stage ii nasopharyngeal carcinoma ajcc v8, stage ii oropharyngeal (p16-negative) carcinoma ajcc v8, stage iii cutaneous squamous cell carcinoma of the head and neck ajcc v8, stage iii hypopharyngeal carcinoma ajcc v8, stage iii laryngeal cancer ajcc v8, stage iii nasopharyngeal carcinoma ajcc v8, stage iii oropharyngeal (p16-negative) carcinoma ajcc v8, unresectable head and neck squamous cell carcinoma, unresectable oropharyngeal squamous cell carcinoma